Compare CSW & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSW | MMSI |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | N/A | 1990 |
| Metric | CSW | MMSI |
|---|---|---|
| Price | $302.91 | $83.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $292.50 | $105.38 |
| AVG Volume (30 Days) | 176.3K | ★ 633.3K |
| Earning Date | 10-30-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | ★ 15.78 | N/A |
| EPS | ★ 8.52 | 1.95 |
| Revenue | $964,795,000.00 | ★ $1,477,128,000.00 |
| Revenue This Year | $22.62 | $13.53 |
| Revenue Next Year | $12.16 | $6.30 |
| P/E Ratio | ★ $35.69 | $42.76 |
| Revenue Growth | ★ 14.87 | 11.41 |
| 52 Week Low | $230.45 | $78.12 |
| 52 Week High | $419.27 | $111.45 |
| Indicator | CSW | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 77.79 | 41.86 |
| Support Level | $267.14 | $83.84 |
| Resistance Level | $273.81 | $88.71 |
| Average True Range (ATR) | 9.18 | 2.04 |
| MACD | 5.47 | -0.45 |
| Stochastic Oscillator | 99.52 | 12.06 |
CSW Industrials Inc is a diversified industrial growth company with well-established, scalable platforms and domain expertise across three segments, Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. The company's Contractor Solutions segment involves manufacturing efficient and performance-enhancing products for residential and commercial HVAC/R and plumbing applications, which are designed for professional end-use customers. Majority of the company revenue is generated from Contractor Solutions segment from U.S. markets.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.